As long as one of the incretins effects is the potentiation of insulin secretion, we investigated in volunteers with normal glucose tolerance, whether incretin-induced insulin secretion is reduced by an acute elevation of plasma lipids, and if an acute reduction of them is able to improve the incretin effect in patients with T2D (76). This evidence concerns the gene GCG and type 2 diabetes mellitus.